Dr Joe Fitchett is medical director at Mologic, a UK-based biotechnology company, and a director of Global Access Diagnostics.
At Mologic, Joe oversees the company’s epidemics portfolio and global access strategy. Accelerated development programs include Yellow Fever, Dengue, Ebola, Measles, and COVID-19.
Prior to Mologic, Joe worked at the Gates Foundation in global policy, advocacy, and resource mobilisation for health, responsible for advancing bilateral partnerships and joint investments with European donor governments. As a Knox Fellow at Harvard, Joe’s research focussed on accelerating access to innovative technologies for neglected epidemics.
Joe trained in medicine and immunology of infectious diseases in the UK, and in public health and infectious disease epidemiology in the US.